Country for PR: United Kingdom
Contributor: PR Newswire Europe
Friday, October 07 2022 - 02:00
Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals
NEW YORK, Oct. 6, 2022, /PRNewswire-AsiaNet/ --

• Synapse Medicine clinical decision support technology analyzes drug-related 
risks based on each patient's clinical characteristics and will be studied for 
its impact on inpatient pharmacist efficacy and efficiency.
• The Synapse Medicine medication reconciliation tool will be deployed through 
an integration with the hospitals' current EPIC EHR workflow.
• The study also has potential to provide improvements to medication regimen 
appropriateness which helps reduce risk of ADEs in hospital and after discharge.

Synapse Medicine, a leader in intelligent medication decision technology, 
announced today it has initiated a clinical study with Brigham and Women's 
Hospital, Boston, MA and the Vanderbilt University Medical Center, Nashville, 
TN to measure the benefits and efficacy of its clinical decision support 
solution and its medication reconciliation software in a hospital setting. The 
principal investigator is Dr. Jeffrey L. Schnipper, MD, MPH, MHM, of the 
Brigham's Division of General Internal Medicine and Primary Care and the 
Hospital Medicine Unit, and Professor of Medicine at Harvard Medical School.

The study, "Effect of Synapse Medicine Decision Support on Inpatient Pharmacist 
Efficacy and Efficiency: A Hybrid Type 2 Implementation Study," engages 
hospital pharmacists at two study sites who round with general medicine service 
teams and approve inpatient medications. Participants will use Synapse Medicine 
point-of-care tools to analyze drug-related risks and optimize medication 
appropriateness. They will also perform medication reconciliation for newly 
admitted patients. The study will measure the usability of Synapse Medicine 
AI-driven clinical decision support and medication reconciliation tools 
quantitatively and qualitatively to determine their impact.

Leveraging real-time data for medication regimen appropriateness

Healthcare systems have long been challenged by the task of drug regimen 
optimization, a critical aspect in a patient's continuity of care. An 
inaccurate medication history or inappropriate drug therapy can burden 
care-providers' efficiency, delay treatment, put patients at risk for 
preventable adverse drug events (ADEs), and contribute to higher readmission 
rates. Hospital-related ADEs are frequent and dangerous, and their management 
has been estimated to cost US$28 billion annually.1

"Hospitalized patients often come to us on suboptimal medication regimens, 
especially too many medications. But we also encounter medications that react 
with each other, incorrect doses based on their kidney function, or medications 
that are inappropriate based on their many medical conditions," said Schnipper. 
"At the same time that we are treating patients' acute medical conditions, we 
also owe it to them to address these longer-standing medication issues and make 
sure we don't introduce any new medication-related problems before they return 

Technology-based clinical decision support creates efficiencies and improves 
patient outcomes

"Optimizing a patient's medication regimen can be a time-consuming and 
complicated process, but it is fundamental to ensuring patient safety and 
therapeutic success," shared Dr. Clement Goehrs, Synapse Medicine CEO and 
Co-Founder. "Collaborating with Brigham and Women's Hospital and Vanderbilt 
University Medical Center allows us to demonstrate how our medication decision 
support technology improves accuracy and streamlines processes creating more 
time for actual patient care and bringing value to all stakeholders."

Synapse Medicine solutions are built on a technology platform that uses machine 
learning and natural language processing. It combines real-time drug knowledge 
with clinical data to detect potential medication risks and discrepancies that 
can lead to ADEs. The suite of clinical decision support tools enables 
healthcare professionals to provide enhanced personalized care for patients. 
The study will evaluate the prescription analysis, drug monograph and 
medication reconciliation solutions for efficiency and accuracy.

About Synapse Medicine

At Synapse Medicine, we believe in medication success, and are dedicated to 
making it possible for everyone.

To achieve this goal, we have built an extensive, global medication knowledge 
base using algorithms to ensure the most reliable, up-to-date data. On the 
front-end, Synapse Medicine provides a SaaS platform and UI components that are 
used to prescribe, dispense, and manage medications across the entire patient 

At Synapse Medicine, we are working with world-leading hospitals and digital 
health companies in the United States, Europe and Japan to transform today's 
medication regimens into tomorrow's medication success.

1.	Weiss, A.J., Freeman, W.J., Heslin, K.C. and Barrett, M.L., 2018. Adverse 
drug events in US hospitals, 2010 versus 2014. HCUP Statistical Brief, 234., +33 (0)5 56 35 50 87 

Logo -

SOURCE: Synapse Medicine